Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Intratumoral Heterogeneity and Chemoradiation Response in Locally Advanced Rectal Cancer Utilizing Sequencing and PET/CT

NCT02132858 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.

NCT NCT02132858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02132858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Intratumoral Heterogeneity and Chemoradiation Response in Locally Advanced Rectal Cancer Utilizing Sequencing and PET/CT
Lead sponsor
Fox Chase Cancer Center
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
October 31, 2022
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucinous adenocarcinoma of the rectum, recurrent rectal cancer, signet ring adenocarcinoma of the rectum, stage iia rectal cancer, stage iib rectal cancer, stage iic rectal cancer, stage iiia rectal cancer, stage iiib rectal cancer, stage iiic rectal cancer